Hepatic stellate cells promote the progression of hepatocellular carcinoma through microRNA-1246-RORα-Wnt/β-Catenin axis
- 13 February 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 476, 140-151
- https://doi.org/10.1016/j.canlet.2020.02.012
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81772510)
- National Key Research and Development Program of China (2017YFC0908101, 2017YFC0908102)
- Research Programs of Science and Technology Commission Foundation of Shanghai (18XD1401100)
- Shanghai Municipal Key Clinical Specialty
This publication has 34 references indexed in Scilit:
- High expression of IL-17 and IL-17RE associate with poor prognosis of hepatocellular carcinomaJournal of Experimental & Clinical Cancer Research, 2013
- RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast CancerInternational Journal of Molecular Sciences, 2012
- Transcription factor RORα is critical for nuocyte developmentNature Immunology, 2012
- Control of Gene Expression by the Retinoic Acid-Related Orphan Receptor Alpha in HepG2 Human Hepatoma CellsPLOS ONE, 2011
- Transcriptional profiling reveals a role for RORα in regulating gene expression in obesity-associated inflammation and hepatic steatosisPhysiological Genomics, 2011
- EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancerOncogene, 2010
- Peritumoral Activated Hepatic Stellate Cells Predict Poor Clinical Outcome in Hepatocellular Carcinoma After Curative ResectionAmerican Journal of Clinical Pathology, 2009
- Neither Multiple Tumors Nor Portal Hypertension Are Surgical Contraindications for Hepatocellular CarcinomaGastroenterology, 2008
- Interleukin-6 regulates hepatic transporters during acute-phase responseBiochemical and Biophysical Research Communications, 2004
- The Hallmarks of CancerCell, 2000